These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26825066)

  • 21. Resistance patterns among nosocomial pathogens: trends over the past few years.
    Jones RN
    Chest; 2001 Feb; 119(2 Suppl):397S-404S. PubMed ID: 11171776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antimicrobial activity of novel globomycin analogues.
    Kiho T; Nakayama M; Yasuda K; Miyakoshi S; Inukai M; Kogen H
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2315-8. PubMed ID: 12824025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antimicrobial properties of 2-(benzylidene-amino)-benzo[d]isothiazol-3-ones.
    Zani F; Vicini P; Incerti M
    Eur J Med Chem; 2004 Feb; 39(2):135-40. PubMed ID: 14987822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ciprofloxacin derivatives and their antibacterial activities.
    Zhang GF; Liu X; Zhang S; Pan B; Liu ML
    Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics.
    Fadli M; Saad A; Sayadi S; Chevalier J; Mezrioui NE; Pagès JM; Hassani L
    Phytomedicine; 2012 Mar; 19(5):464-71. PubMed ID: 22257599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
    Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors.
    Cooper IR; McCarroll AJ; McGarry D; Kirkham J; Pichowicz M; Walker R; Warrilow C; Salisbury AM; Savage VJ; Moyo E; Forward H; Cheung J; Metzger R; Gault Z; Nelson G; Hughes D; Cao S; Maclean J; Charrier C; Craighead M; Best S; Stokes NR; Ratcliffe AJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4179-83. PubMed ID: 27499455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antibacterial activity of thiazolo-, oxazolo-, and imidazolo[3,2-a][1,8]naphthyridinecarboxylic acids.
    Kondo H; Taguchi M; Inoue Y; Sakamoto F; Tsukamoto G
    J Med Chem; 1990 Jul; 33(7):2012-5. PubMed ID: 2163456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres. The Canadian Antimicrobial Study Group.
    Blondeau JM; Vaughan D
    Int J Antimicrob Agents; 2000 Aug; 15(3):213-9. PubMed ID: 10926444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile regioselective synthesis of novel bis-thiazole derivatives and their antimicrobial activity.
    Mahmoodi NO; Parvizi J; Sharifzadeh B; Rassa M
    Arch Pharm (Weinheim); 2013 Dec; 346(12):860-4. PubMed ID: 24136795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
    Hosgor-Limoncu M; Ermertcan S; Tasli H; Yurtman AN
    West Indian Med J; 2008 Mar; 57(2):106-11. PubMed ID: 19565951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activities of spirooxindolopyrrolidine tethered dicarbonitrile heterocycles against multidrug resistant nosocomial pathogens.
    Arumugam N; Almansour AI; Suresh Kumar R
    J Infect Public Health; 2021 Dec; 14(12):1810-1814. PubMed ID: 34776342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel oxazolidinone-quinolone hybrid antimicrobials.
    Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
    Wang S; Jia XD; Liu ML; Lu Y; Guo HY
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new synthesis of oxadiazole, thiazolidinone, N-phthalimidoamino carbonyl and arylidene derivatives with potential antimicrobial activity.
    Hassaneen HM; Atta SM; Fawzy NM; Ahmed FA; Hegazi AG; Abdalla FA; Abd El Rahman AH
    Arch Pharm (Weinheim); 2002 Jun; 335(6):251-61. PubMed ID: 12210767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro antibacterial activity of 3-[N-methyl-N-(3-methyl-1,3-thiazolium-2-yl)aminolmethyl cephalosporin derivatives.
    Kim SH; Son H; Nam G; Chi DY; Kim JH
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1143-5. PubMed ID: 10866367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial gram-negative bloodstream isolates: a comparison of in vitro antibiotic potency.
    Stanley GL; Pfaller MA; Mori M; Wenzel RP
    J Hosp Infect; 1989 Oct; 14(3):217-25. PubMed ID: 2575103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia.
    Ferrara AM
    Int J Antimicrob Agents; 2006 Mar; 27(3):183-95. PubMed ID: 16472990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.